Radiolysis, Photolysis, Sonolysis and Sonoprotection of
Radiolysis, Photolysis, Sonolysis and Sonoprotection of
批准号:
7331390
负责人:
JAMES B MITCHELL
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
我们的实验室首先证明了氮氧化物(如Tempol)是有效的抗氧化剂和抗电离辐射损伤的保护剂。一氧化氮介导的抗氧化应激保护机制包括超氧化物歧化酶和过氧化氢酶样活性以及自由基-自由基反应。然而,最近更多的研究集中在氮氧化物处理是否影响基因表达。用无毒浓度的几种不同的氮氧化物类似物处理细胞;包括不能进入(和保护)细胞的氮氧化物都表现出相似的基因表达模式。比较暴露于氮氧化物和各种形式的氧化应激(过氧化氢、超氧化物、一氧化氮和电离辐射)的MCF7细胞的基因表达谱。有趣的是,与炎症反应相关的一小部分基因在所有形式的氧化应激中都被上调;然而,同样的基因在氮氧化物处理下都是下调的。这些研究将为氮氧化物的辐射防护特性提供更多的见解,特别是关于Tempol对正常组织和肿瘤的不同辐射防护。分次放射治疗前10分钟给予Tempol不能保护SCC和HT-29肿瘤的生长;然而,以同样的方式施用Tempol可以防止辐射引起的唾液腺损伤。我们的实验室最近取得了重大进展,可以用来解释这种差异。氮氧化物可以用作功能性MRI对比探针,用于确定组织氧化还原状态。我们已经表明,Tempol在肿瘤组织中比在唾液腺组织中更快地被还原为非辐射防护羟胺。因此,基于氮氧化物的MRI研究有可能指导适当的氮氧化物给药时间,从而在不保护肿瘤的情况下对正常组织产生最大的放射保护。与放射肿瘤学分支合作,已提交I期临床试验(首次在人体中进行),以评估Tempol作为功能性MRI造影剂。由于氮氧化物很容易穿透细胞膜,是有效的抗氧化剂,它们可能用于其他医学研究领域,如缺血/再灌注损伤研究,预防白内障,炎症过程和衰老。此外,基于氮氧化物的MRI评估可用于确定上述情况的临床应用。最后,我们继续寻找长期服用Tempol(在食物或饮用水中)如何导致小鼠体重显著减轻和自发性肿瘤发生率降低的机制。Tempol也可以延缓Atm和p53缺陷小鼠的肿瘤发生。我们最近发现,在Tempol治疗的动物中,IGF-1的全身水平下降,与在热量限制动物中观察到的情况相似。这些研究有望使我们更好地了解氮氧化物的复杂细胞/分子机制,这些机制触发了氮氧化物抗氧化性能的重要反应,以及与体重和化学预防相关的反应。
英文摘要
Nitroxides as Protectors against Oxidative StressOur laboratory was first to demonstrate that nitroxides (such as Tempol) are effective antioxidants and protectors against ionizing radiation damage. The mechanism(s) for nitroxide-mediated protection against oxidative stress include superoxide dismutase- and catalase-like activity and radical-radical reactions. However, more recent studies have focused on whether nitroxide treatment impacts gene expression. Cells treated with non-toxic concentrations of several different nitroxide analogues; including a nitroxide incapable of cellular entry (and protection) all exhibit similar patterns of gene expression. A comparison was made of gene expression profiles for MCF7 cells exposed to nitroxides and various forms of oxidative stress (hydrogen peroxide, superoxide, nitric oxide, and ionizing radiation). Interestingly, a small subset of genes related to inflammatory responses was up regulated for all forms of oxidative stress; whereas, the same genes for nitroxide treatment were all down regulated. These studies will provide additional insight into the radio-protective properties of nitroxides, particularly with respect to the differential radioprotection of Tempol toward normal tissues as opposed to tumor. Tempol administered 10 min prior to fractionated radiation treatment does not protect SCC and HT-29 tumor growth; whereas, Tempol administered in the same fashion protects against radiation-induced salivary gland damage. Our lab has made a recent major advancement that can be used to explain this difference. Nitroxides can be used as functional MRI contrast probes allowing for determination of tissue redox status. We have shown that Tempol is reduced in tumor tissue to the non-radioprotective hydroxylamine faster than in salivary gland tissue. Nitroxide based MRI studies thus have the potential to guide to appropriate timing of nitroxide administration to yield maximal radioprotection of normal tissues without protection of tumor. In collaboration with the Radiation Oncology Branch a Phase I clinical trail (first in humans) has been submitted to evaluate Tempol as a functional MRI contrast probe. Since nitroxides readily penetrate cell membranes and are potent antioxidants, they may be of use in other areas of medical research such as ischemia/reperfusion injury studies, prevention of cataracts, inflammatory processes, and aging. Additionally, nitroxide based MRI evaluation may clinical utility in defining the above-mentioned conditions. Lastly, we continue to seek the mechanism of how long-term administration of Tempol (in the food or drinking water) results in dramatic weight reduction and a decrease in spontaneous tumor incidence in mice. Tempol administration also delays the onset of tumors in Atm and p53 deficient mice. We have recently found that systemic levels of IGF-1 are decreased in Tempol treated animals, similar to that observed in caloric restricted animals. These studies will hopefully enable us to better understand the complex cellular/molecular mechanisms of nitroxides that trigger responses important in the antioxidant properties of nitroxides as well as those related to weight and the chemopreventive findings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of Therapeutic Response
-
批准号:6947107
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:7594762
-
项目类别:
-
资助金额:$63.51万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
NITROXIDES AS PROTECTORS AGAINST OXIDATIVE STRESS
-
批准号:6290749
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:7292012
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:7331383
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:7292006
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:7594757
-
项目类别:
-
资助金额:$63.51万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:7735357
-
项目类别:
-
资助金额:$44.88万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:7066825
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:6756256
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:6433342
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:6558297
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:6558332
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:6756263
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:7735362
-
项目类别:
-
资助金额:$44.88万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
MODULATION OF THERAPEUTIC RESPONSE
-
批准号:6290743
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:6433348
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
海外基金